en Experimental Neurobiology

Cited by CrossRef (20)

  1. Matteo Apicella, Maria Cristina Campopiano, Michele Mantuano, Laura Mazoni, Stefano Del Prato. Guida pratica alla prevenzione e gestione dell’infezione da COVID-19 nelle persone con diabete. L'Endocrinologo 2020;21:241
    https://doi.org/10.1007/s40619-020-00767-3
  2. Luiza P. Géa, Eduarda D. da Rosa, Bruna S. Panizzutti, Érica Z. de Aguiar, Larissa F. de Oliveira, Pamela Ferrari, Angelo Piato, Rosane Gomez, Rafael Colombo, Adriane R. Rosa. Reduction of hippocampal IL-6 levels in LPS-injected rats following acute exendin-4 treatment. Naunyn-Schmiedeberg's Arch Pharmacol 2020;393:1303
    https://doi.org/10.1007/s00210-020-01867-5
  3. Diego Incontri Abraham, Melissa Gonzales, Antonio Ibarra, Cesar V. Borlongan. Stand alone or join forces? Stem cell therapy for stroke. Expert Opinion on Biological Therapy 2019;19:25
    https://doi.org/10.1080/14712598.2019.1551872
  4. Shan-Shan Cui, Xiao-Bo Feng, Bing-Hong Zhang, Zhong-Yuan Xia, Li-Ying Zhan. Exendin-4 attenuates pain-induced cognitive impairment by alleviating hippocampal neuroinflammation in a rat model of spinal nerve ligation. Neural Regen Res 2020;15:1333
    https://doi.org/10.4103/1673-5374.272620
  5. Eridan Rocha-Ferreira, Laura Poupon, Aura Zelco, Anna-Lena Leverin, Syam Nair, Andrea Jonsdotter, Ylva Carlsson, Claire Thornton, Henrik Hagberg, Ahad A Rahim. Neuroprotective exendin-4 enhances hypothermia therapy in a model of hypoxic-ischaemic encephalopathy. 2018;141:2925
    https://doi.org/10.1093/brain/awy220
  6. Mark P Maskery, Christian Holscher, Stephanie P Jones, Christopher I Price, W David Strain, Caroline L Watkins, David J Werring, Hedley C.A. Emsley. Glucagon like peptide-1 receptor agonists as neuroprotective agents for ischemic stroke: a systematic scoping review. J Cereb Blood Flow Metab 2020:0271678X2095201
    https://doi.org/10.1177/0271678X20952011
  7. Francesco Bifari, Roberto Manfrini, Michele Dei Cas, Cesare Berra, Matteo Siano, Massimo Zuin, Rita Paroni, Franco Folli. Multiple target tissue effects of GLP-1 analogues on non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). Pharmacological Research 2018;137:219
    https://doi.org/10.1016/j.phrs.2018.09.025
  8. Xinwang Yang, Ying Wang, Chunyun Wu, Eng-Ang Ling. Animal Venom Peptides as a Treasure Trove for New Therapeutics Against Neurodegenerative Disorders. CMC 2019;26:4749
    https://doi.org/10.2174/0929867325666181031122438
  9. Jian Xu, Guihong Wei, Jingjing Wang, Jiali Zhu, Min Yu, Xiaoning Zeng, Hong Wang, Weiping Xie, Hui Kong. Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function. Lab Invest 2019;99:577
    https://doi.org/10.1038/s41374-018-0170-0
  10. Dimitrios Milonas, Triantafyllos Didangelos, Apostolos I. Hatzitolios, Konstantinos Tziomalos. Incretin-Based Antihyperglycemic Agents for the Management of Acute Ischemic Stroke in Patients with Diabetes Mellitus: A Review. Diabetes Ther 2019;10:429
    https://doi.org/10.1007/s13300-019-0580-z
  11. Damla Erbil, Candan Yasemin Eren, Cağrı Demirel, Mehmet Utku Küçüker, Ihsan Solaroğlu, Hale Yapıcı Eser. GLP-1’s role in neuroprotection: a systematic review. Brain Injury 2019;33:734
    https://doi.org/10.1080/02699052.2019.1587000
  12. Chang Ho Ahn, Soo Lim. Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke. J Stroke 2019;21:139
    https://doi.org/10.5853/jos.2019.00038
  13. Eleni Xourgia, Eleni-Margarita Tzouganatou, Athanasia Papazafiropoulou, Andreas Melidonis. Anti-inflammatory properties of antidiabetic agents. WJMA 2019;7:129
    https://doi.org/10.13105/wjma.v7.i4.129
  14. Emőke Horváth, Adina Huțanu, Liviu Chiriac, Minodora Dobreanu, Alex Orădan, Előd-Ernő Nagy. Ischemic damage and early inflammatory infiltration are different in the core and penumbra lesions of rat brain after transient focal cerebral ischemia. Journal of Neuroimmunology 2018;324:35
    https://doi.org/10.1016/j.jneuroim.2018.08.002
  15. Łukasz Bułdak, Grzegorz Machnik, Estera Skudrzyk, Aleksandra Bołdys, Bogusław Okopień. The impact of exenatide (a GLP‑1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions. Exp Ther Med 2019
    https://doi.org/10.3892/etm.2019.7245
  16. Soo Lim, Tae Jung Oh, Jesse Dawson, Naveed Sattar. Diabetes drugs and stroke risk: Intensive versus conventional glucose‐lowering strategies, and implications of recent cardiovascular outcome trials. Diabetes Obes Metab 2020;22:6
    https://doi.org/10.1111/dom.13850
  17. Jing Sun, Suzhi Liu, Zongxin Ling, Fangyan Wang, Yi Ling, Tianyu Gong, Na Fang, Shiqing Ye, Jue Si, Jiaming Liu. Fructooligosaccharides Ameliorating Cognitive Deficits and Neurodegeneration in APP/PS1 Transgenic Mice through Modulating Gut Microbiota. J. Agric. Food Chem. 2019;67:3006
    https://doi.org/10.1021/acs.jafc.8b07313
  18. Arashdeep Singh, Rizaldy C. Zapata, Adel Pezeshki, Matthew L. Workentine, Prasanth K. Chelikani. Host genetics and diet composition interact to modulate gut microbiota and predisposition to metabolic syndrome in spontaneously hypertensive stroke‐prone rats. FASEB j. 2019;33:6748
    https://doi.org/10.1096/fj.201801627RRR
  19. Tram Thi Ngoc Nguyen, Hojung Choi, Hee-Sook Jun. Preventive Effects of Dulaglutide on Disuse Muscle Atrophy Through Inhibition of Inflammation and Apoptosis by Induction of Hsp72 Expression. Front. Pharmacol. 2020;11
    https://doi.org/10.3389/fphar.2020.00090
  20. Maria Shvedova, Yana Anfinogenova, Elena N. Atochina-Vasserman, Igor A. Schepetkin, Dmitriy N. Atochin. c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury. Front. Pharmacol. 2018;9
    https://doi.org/10.3389/fphar.2018.00715